| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Vitrolife AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr13.30 |
| 52 Week High | kr21.49 |
| 52 Week Low | kr11.45 |
| Beta | 1.56 |
| 1 Month Change | 0% |
| 3 Month Change | 16.16% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 12.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| VTRL.Y | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 3.9% | 3.3% |
| 1Y | n/a | 3.4% | 25.8% |
Return vs Industry: Insufficient data to determine how VTRL.Y performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how VTRL.Y performed against the US Market.
Price Volatility
| VTRL.Y volatility | |
|---|---|
| VTRL.Y Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VTRL.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine VTRL.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 1,109 | Bronwyn Brophy | www.vitrolife.com |
Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems.
Vitrolife AB (publ) Fundamentals Summary
| VTRL.Y fundamental statistics | |
|---|---|
| Market cap | US$2.26b |
| Earnings (TTM) | US$38.37m |
| Revenue (TTM) | US$330.48m |
58.8x
P/E Ratio6.8x
P/S RatioIs VTRL.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VTRL.Y income statement (TTM) | |
|---|---|
| Revenue | kr3.46b |
| Cost of Revenue | kr1.54b |
| Gross Profit | kr1.93b |
| Other Expenses | kr1.52b |
| Earnings | kr402.00m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 02, 2024
| Earnings per share (EPS) | 2.97 |
| Gross Margin | 55.63% |
| Net Profit Margin | 11.61% |
| Debt/Equity Ratio | 11.8% |
How did VTRL.Y perform over the long term?
See historical performance and comparison